부산대학교 도서관

Rose ES; Vanderbilt Institute for Global Health, Vanderbilt University Medical Center, Nashville, Tennessee.; Nzala SH; Department of Medical Education Development, University of Zambia, Lusaka, Zambia.; Goma FM; Health Professions Council of Zambia, Lusaka, Zambia.; Gavarkavich D; DTG Community Services, Charlotte, North Carolina.; Deepak A; Tennessee Department of Health, Nashville, Tennessee.; Parker OJ; United States of America Fulbright Program, Hanoi, Vietnam.; Chi BH; Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Reed K; Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Heimburger DC; Vanderbilt Institute for Global Health, Vanderbilt University Medical Center, Nashville, Tennessee.; Department of Medical Education Development, University of Zambia, Lusaka, Zambia.; Martin MH; Vanderbilt Institute for Global Health, Vanderbilt University Medical Center, Nashville, Tennessee.

Publisher: American Society of Tropical Medicine and Hygiene Country of Publication: United States NLM ID: 0370507 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1476-1645 (Electronic) Linking ISSN: 00029637 NLM ISO Abbreviation: Am J Trop Med Hyg Subsets: MEDLINE

Fulbright OJ; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, TX, USA.; Forget MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, TX, USA.; Haymaker C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, TX, USA.; Bernatchez C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, TX, USA. cbernatchez@mdanderson.org.

Publisher: Humana Press Country of Publication: United States NLM ID: 9214969 Publication Model: Print Cited Medium: Internet ISSN: 1940-6029 (Electronic) Linking ISSN: 10643745 NLM ISO Abbreviation: Methods Mol Biol Subsets: MEDLINE

Tavera RJ; Departments of Melanoma Medical Oncology.; Forget MA; Departments of Melanoma Medical Oncology.; Kim YU; Departments of Melanoma Medical Oncology.; Sakellariou-Thompson D; Departments of Melanoma Medical Oncology.; Creasy CA; Departments of Melanoma Medical Oncology.; Bhatta A; Departments of Melanoma Medical Oncology.; Fulbright OJ; Departments of Melanoma Medical Oncology.; Ramachandran R; Departments of Melanoma Medical Oncology.; Thorsen ST; Departments of Melanoma Medical Oncology.; Flores E; Departments of Melanoma Medical Oncology.; Wahl A; Departments of Melanoma Medical Oncology.; Gonzalez AM; Departments of Melanoma Medical Oncology.; Toth C; Departments of Melanoma Medical Oncology.; Wardell S; Departments of Melanoma Medical Oncology.; Mansaray R; Departments of Melanoma Medical Oncology.; Radvanyi LG; Departments of Melanoma Medical Oncology.; Gombos DS; Head and Neck Surgery, The University of Texas MD Anderson Cancer Center (MDACC), Houston, TX.; Patel SP; Departments of Melanoma Medical Oncology.; Hwu P; Departments of Melanoma Medical Oncology.; Amaria RN; Departments of Melanoma Medical Oncology.; Bernatchez C; Departments of Melanoma Medical Oncology.; Haymaker C; Departments of Melanoma Medical Oncology.

Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9706083 Publication Model: Print Cited Medium: Internet ISSN: 1537-4513 (Electronic) Linking ISSN: 15249557 NLM ISO Abbreviation: J Immunother Subsets: MEDLINE

Forget MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.; Haymaker C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.; Hess KR; Department of Biostatistics, The University of Texas MDACC, Houston, Texas.; Meng YJ; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Creasy C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.; Karpinets T; Department of Genomic Medicine, The University of Texas MDACC, Houston, Texas.; Fulbright OJ; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.; Roszik J; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.; Department of Genomic Medicine, The University of Texas MDACC, Houston, Texas.; Woodman SE; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.; Kim YU; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.; Sakellariou-Thompson D; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.; Bhatta A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.; Wahl A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.; Flores E; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.; Thorsen ST; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.; Tavera RJ; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.; Ramachandran R; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.; Gonzalez AM; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.; Toth CL; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.; Wardell S; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.; Mansaray R; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.; Patel V; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.; Carpio DJ; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.; Vaughn C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.; Farinas CM; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.; Velasquez PG; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.; Hwu WJ; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.; Patel SP; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.; Davies MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.; Diab A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.; Glitza IC; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.; Tawbi H; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.; Wong MK; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.; Cain S; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.; Ross MI; Department of Surgical Oncology, The University of Texas MDACC, Houston, Texas.; Lee JE; Department of Surgical Oncology, The University of Texas MDACC, Houston, Texas.; Gershenwald JE; Department of Surgical Oncology, The University of Texas MDACC, Houston, Texas.; Lucci A; Department of Surgical Oncology, The University of Texas MDACC, Houston, Texas.; Royal R; Department of Surgical Oncology, The University of Texas MDACC, Houston, Texas.; Cormier JN; Department of Surgical Oncology, The University of Texas MDACC, Houston, Texas.; Wargo JA; Department of Genomic Medicine, The University of Texas MDACC, Houston, Texas.; Department of Surgical Oncology, The University of Texas MDACC, Houston, Texas.; Radvanyi LG; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.; Torres-Cabala CA; Department of Pathology, The University of Texas MDACC, Houston, Texas.; Beroukhim R; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Hwu P; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.; Amaria RN; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas. cbernatchez@mdanderson.org rnamaria@mdanderson.org.; Bernatchez C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas. cbernatchez@mdanderson.org rnamaria@mdanderson.org.

Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Forget MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, TX, United States.; Tavera RJ; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, TX, United States.; Haymaker C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, TX, United States.; Ramachandran R; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, TX, United States.; Malu S; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, TX, United States.; Zhang M; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, TX, United States.; Wardell S; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, TX, United States.; Fulbright OJ; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, TX, United States.; Toth CL; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, TX, United States.; Gonzalez AM; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, TX, United States.; Thorsen ST; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, TX, United States.; Flores E; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, TX, United States.; Wahl A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, TX, United States.; Peng W; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, TX, United States.; Amaria RN; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, TX, United States.; Hwu P; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, TX, United States.; Bernatchez C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, TX, United States.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Print ISSN: 1664-3224 (Print) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: PubMed not MEDLINE

Qin Y; Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.; Petaccia de Macedo M; Department of Translational Molecular Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.; Reuben A; Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.; Forget MA; Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.; Haymaker C; Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.; Bernatchez C; Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.; Spencer CN; Department of Genomic Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.; Gopalakrishnan V; Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.; Reddy S; Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.; Cooper ZA; Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.; Fulbright OJ; Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.; Ramachandran R; Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.; Wahl A; Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.; Flores E; Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.; Thorsen ST; Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.; Tavera RJ; Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.; Conrad C; Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.; Williams MD; Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.; Tetzlaff MT; Department of Translational Molecular Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.; Wang WL; Department of Translational Molecular Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.; Gombos DS; Section of Ophthalmology, Department of Head and Neck Surgery and The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.; Esmaeli B; Orbital Oncology and Ophthalmic Plastic Surgery, Department of Plastic Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.; Amaria RN; Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.; Hwu P; Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.; Wargo JA; Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.; Lazar AJ; Department of Translational Molecular Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.; Patel SP; Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: PubMed not MEDLINE

Glitza IC; Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. icglitza@mdanderson.org.; Haymaker C; Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Bernatchez C; Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Vence L; Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Rohlfs M; Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Richard J; Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Lacey C; Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Mansaray R; Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Fulbright OJ; Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Ramachandran R; Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Toth C; Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Wardell S; Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Patel SP; Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Woodman SE; Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Hwu WJ; Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Radvanyi LG; Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Davies MA; Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Papadopoulos NE; Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Hwu P; Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE

Forget MA; Department of Melanoma Medical Oncology; The University of Texas MD Anderson Cancer Center (MDACC) ; Houston, TX USA.; Haymaker C; Department of Melanoma Medical Oncology; The University of Texas MD Anderson Cancer Center (MDACC) ; Houston, TX USA.; Dennison JB; Department of Systems Biology; The University of Texas MDACC ; Houston, TX USA.; Toth C; Department of Melanoma Medical Oncology; The University of Texas MD Anderson Cancer Center (MDACC) ; Houston, TX USA.; Maiti S; Division of Pediatrics; The University of Texas MDACC ; Houston, TX USA.; Fulbright OJ; Department of Melanoma Medical Oncology; The University of Texas MD Anderson Cancer Center (MDACC) ; Houston, TX USA.; Cooper LJ; Division of Pediatrics; The University of Texas MDACC ; Houston, TX USA.; Hwu P; Department of Melanoma Medical Oncology; The University of Texas MD Anderson Cancer Center (MDACC) ; Houston, TX USA.; Radvanyi LG; Department of Melanoma Medical Oncology; The University of Texas MD Anderson Cancer Center (MDACC); Houston, TX USA; Lion Biotechnologies; Tampa, FL USA; Department of Immunology; H. Lee Moffitt Cancer Center; Tampa, FL USA.; Bernatchez C; Department of Melanoma Medical Oncology; The University of Texas MD Anderson Cancer Center (MDACC) ; Houston, TX USA.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: PubMed not MEDLINE

Radvanyi LG; Departments of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. lradvanyi@mdanderson.org; Bernatchez C; Zhang M; Fox PS; Miller P; Chacon J; Wu R; Lizee G; Mahoney S; Alvarado G; Glass M; Johnson VE; McMannis JD; Shpall E; Prieto V; Papadopoulos N; Kim K; Homsi J; Bedikian A; Hwu WJ; Patel S; Ross MI; Lee JE; Gershenwald JE; Lucci A; Royal R; Cormier JN; Davies MA; Mansaray R; Fulbright OJ; Toth C; Ramachandran R; Wardell S; Gonzalez A; Hwu P

Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Liu S; Department of Melanoma Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA.; Etto T; Rodríguez-Cruz T; Li Y; Wu C; Fulbright OJ; Hwu P; Radvanyi L; Lizée G

Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9706083 Publication Model: Print Cited Medium: Internet ISSN: 1537-4513 (Electronic) Linking ISSN: 15249557 NLM ISO Abbreviation: J Immunother Subsets: MEDLINE